Evidence map›Paper›PMID 38455658›Full record

ArticleFrontiers in endocrinology2024

Infertility in Fabry's Disease: role of hypoxia and inflammation in determining testicular damage.

Luigi Sansone, Federica Barreca, Manuel Belli, Michele Aventaggiato, Andrea Russo, Giulietta A Perrone, Matteo A Russo, Marco Tafani, Andrea Frustaci

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Luigi Sansone *Laboratory of Cellular and Molecular Pathology, IRCCS San Raffaele, Rome, Italy.
Federica Barreca *Laboratory of Cellular and Molecular Pathology, Department of Experimental Medicine, Sapienza University, Rome, Italy.
Manuel BelliLaboratory of Cellular and Molecular Pathology, IRCCS San Raffaele, Rome, Italy.
Michele AventaggiatoLaboratory of Cellular and Molecular Pathology, Department of Experimental Medicine, Sapienza University, Rome, Italy.
Andrea RussoDepartment of Pathologic Anatomy, IRCCS Regina Elena, Rome, Italy.
Giulietta A PerroneUOC of Pathologic Anatomy, San Filippo Neri Hospital, Rome, Italy.
Matteo A RussoLaboratory of Cellular and Molecular Pathology, IRCCS San Raffaele, Rome, Italy.
Marco Tafani *Laboratory of Cellular and Molecular Pathology, Department of Experimental Medicine, Sapienza University, Rome, Italy.
Andrea Frustaci *Laboratory of Cellular and Molecular Pathology, IRCCS San Raffaele, Rome, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITSapienza University of Rome · ITIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleOspedale San Filippo Neri · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fabry's disease (FD) is a genetic X-linked systemic and progressive rare disease characterized by the accumulation of globotriaosylceramide (GB3) into the lysosomes of many tissues. FD is due to loss-of-function mutations of α-galactosidase, a key-enzyme for lysosomal catabolism of glycosphingolipids, which accumulate as glycolipid bodies (GB). In homozygous males the progressive deposition of GB3 into the cells leads to clinical symptoms in CNS, skin, kidney, etc. In testis GB accumulation causes infertility and alterations of spermatogenesis. However, the precise damaging mechanism is still unknown. Our hypothesis is that GB accumulation reduces blood vessel lumen and increases the distance of vessels from both stromal cells and seminiferous parenchyma; this, in turn, impairs oxygen and nutrients diffusion leading to subcellular degradation of seminiferous epithelium and sterility. Methods: To test this hypothesis, we have studied a 42-year-old patient presenting a severe FD and infertility, with reduced number of spermatozoa, but preserved sexual activity. Testicular biopsies were analyzed by optical (OM) and transmission electron microscopy (TEM). Activation and cellular localization of HIF-1α and NFκB was analyzed by immunofluorescence (IF) and RT-PCR on homogeneous tissue fractions after laser capture microdissection (LCMD). Results: OM and TEM showed that GB were abundant in vessel wall cells and in interstitial cells. By contrast, GB were absent in seminiferous epithelium, Sertoli's and Leydig's cells. However, seminiferous tubular epithelium and Sertoli's cells showed reduced diameter, thickening of basement membrane and tunica propria, and swollen or degenerated spermatogonia. IF showed an accumulation of HIF-1α in stromal cells but not in seminiferous tubules. On the contrary, NFκB fluorescence was evident in tubules, but very low in interstitial cells. Finally, RT-PCR analysis on LCMD fractions showed the expression of pro-inflammatory genes connected to the HIF-1α/NFκB inflammatory-like pathway. Conclusion: Our study demonstrates that infertility in FD may be caused by reduced oxygen and nutrients due to GB accumulation in blood vessels cells. Reduced oxygen and nutrients alter HIF-1α/NFκB expression and localization while activating HIF-1α/NFκB driven-inflammation-like response damaging seminiferous tubular epithelium and Sertoli's cells.

Indexed as

Fabry DiseaseInfertilityAdultHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitInflammationMaleNF-kappa B p50 SubunitOxygenTestisHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNF-kappa B p50 SubunitNFKB1 protein, humanOxygencellular and molecular rehabilitationFabry’s diseasehypoxiainflammationnew therapeutic targets for infertility rehabilitationtesticular damage

Identifiers

PMID38455658
PMCPMC10917934
OpenAlexW4392056214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.